The global In-Vitro Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The market for in-vitro cancer diagnostics is driven by the growing burden of cancer and the need for early and accurate cancer detection. The market's growth is also influenced by the development of novel biomarkers and advanced diagnostic technologies, leading to improved sensitivity and specificity of cancer tests.

This report aims to provide a comprehensive presentation of the global market for In-Vitro Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Cancer Diagnostics.

Report Scope

The In-Vitro Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Vitro Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the In-Vitro Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of In-Vitro Cancer Diagnostics Market Report

Report Metric	Details
Report Name	In-Vitro Cancer Diagnostics Market
Segment by Type	Instruments Reagents and Kits
Segment by Application	Laboratories Hospitals Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	MDx Health Quest Diagnostics, R-Biopharm AG, Signature Diagnostics, Siemens Healthcare, Randox Laboratories, Epigenomics AG, Beckman Coulter, Abbott Laboratories, Burning Rock, Novogene, Geneseeq, Amoy Diagnostics Co.,Ltd., Daan Gene, Fosun Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Vitro Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the In-Vitro Cancer Diagnostics Market report?

Ans: The main players in the In-Vitro Cancer Diagnostics Market are MDx Health Quest Diagnostics, R-Biopharm AG, Signature Diagnostics, Siemens Healthcare, Randox Laboratories, Epigenomics AG, Beckman Coulter, Abbott Laboratories, Burning Rock, Novogene, Geneseeq, Amoy Diagnostics Co.,Ltd., Daan Gene, Fosun Pharma

What are the Application segmentation covered in the In-Vitro Cancer Diagnostics Market report?

Ans: The Applications covered in the In-Vitro Cancer Diagnostics Market report are Laboratories, Hospitals, Others

What are the Type segmentation covered in the In-Vitro Cancer Diagnostics Market report?

Ans: The Types covered in the In-Vitro Cancer Diagnostics Market report are Instruments, Reagents and Kits

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Instruments

1.2.3 Reagents and Kits

1.3 Market by Application

1.3.1 Global In-Vitro Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Laboratories

1.3.3 Hospitals

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global In-Vitro Cancer Diagnostics Market Perspective (2019-2030)

2.2 In-Vitro Cancer Diagnostics Growth Trends by Region

2.2.1 Global In-Vitro Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 In-Vitro Cancer Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 In-Vitro Cancer Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 In-Vitro Cancer Diagnostics Market Dynamics

2.3.1 In-Vitro Cancer Diagnostics Industry Trends

2.3.2 In-Vitro Cancer Diagnostics Market Drivers

2.3.3 In-Vitro Cancer Diagnostics Market Challenges

2.3.4 In-Vitro Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue

3.1.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue (2019-2024)

3.1.2 Global In-Vitro Cancer Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by In-Vitro Cancer Diagnostics Revenue

3.4 Global In-Vitro Cancer Diagnostics Market Concentration Ratio

3.4.1 Global In-Vitro Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Cancer Diagnostics Revenue in 2023

3.5 In-Vitro Cancer Diagnostics Key Players Head office and Area Served

3.6 Key Players In-Vitro Cancer Diagnostics Product Solution and Service

3.7 Date of Enter into In-Vitro Cancer Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 In-Vitro Cancer Diagnostics Breakdown Data by Type

4.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2025-2030)

5 In-Vitro Cancer Diagnostics Breakdown Data by Application

5.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America In-Vitro Cancer Diagnostics Market Size (2019-2030)

6.2 North America In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)

6.4 North America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe In-Vitro Cancer Diagnostics Market Size (2019-2030)

7.2 Europe In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)

7.4 Europe In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America In-Vitro Cancer Diagnostics Market Size (2019-2030)

9.2 Latin America In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)

9.4 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 MDx Health Quest Diagnostics

11.1.1 MDx Health Quest Diagnostics Company Detail

11.1.2 MDx Health Quest Diagnostics Business Overview

11.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Introduction

11.1.4 MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.1.5 MDx Health Quest Diagnostics Recent Development

11.2 R-Biopharm AG

11.2.1 R-Biopharm AG Company Detail

11.2.2 R-Biopharm AG Business Overview

11.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Introduction

11.2.4 R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.2.5 R-Biopharm AG Recent Development

11.3 Signature Diagnostics

11.3.1 Signature Diagnostics Company Detail

11.3.2 Signature Diagnostics Business Overview

11.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Introduction

11.3.4 Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.3.5 Signature Diagnostics Recent Development

11.4 Siemens Healthcare

11.4.1 Siemens Healthcare Company Detail

11.4.2 Siemens Healthcare Business Overview

11.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Introduction

11.4.4 Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.4.5 Siemens Healthcare Recent Development

11.5 Randox Laboratories

11.5.1 Randox Laboratories Company Detail

11.5.2 Randox Laboratories Business Overview

11.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Introduction

11.5.4 Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.5.5 Randox Laboratories Recent Development

11.6 Epigenomics AG

11.6.1 Epigenomics AG Company Detail

11.6.2 Epigenomics AG Business Overview

11.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Introduction

11.6.4 Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.6.5 Epigenomics AG Recent Development

11.7 Beckman Coulter

11.7.1 Beckman Coulter Company Detail

11.7.2 Beckman Coulter Business Overview

11.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Introduction

11.7.4 Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.7.5 Beckman Coulter Recent Development

11.8 Abbott Laboratories

11.8.1 Abbott Laboratories Company Detail

11.8.2 Abbott Laboratories Business Overview

11.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Introduction

11.8.4 Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.8.5 Abbott Laboratories Recent Development

11.9 Burning Rock

11.9.1 Burning Rock Company Detail

11.9.2 Burning Rock Business Overview

11.9.3 Burning Rock In-Vitro Cancer Diagnostics Introduction

11.9.4 Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.9.5 Burning Rock Recent Development

11.10 Novogene

11.10.1 Novogene Company Detail

11.10.2 Novogene Business Overview

11.10.3 Novogene In-Vitro Cancer Diagnostics Introduction

11.10.4 Novogene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.10.5 Novogene Recent Development

11.11 Geneseeq

11.11.1 Geneseeq Company Detail

11.11.2 Geneseeq Business Overview

11.11.3 Geneseeq In-Vitro Cancer Diagnostics Introduction

11.11.4 Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.11.5 Geneseeq Recent Development

11.12 Amoy Diagnostics Co.,Ltd.

11.12.1 Amoy Diagnostics Co.,Ltd. Company Detail

11.12.2 Amoy Diagnostics Co.,Ltd. Business Overview

11.12.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Introduction

11.12.4 Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.12.5 Amoy Diagnostics Co.,Ltd. Recent Development

11.13 Daan Gene

11.13.1 Daan Gene Company Detail

11.13.2 Daan Gene Business Overview

11.13.3 Daan Gene In-Vitro Cancer Diagnostics Introduction

11.13.4 Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.13.5 Daan Gene Recent Development

11.14 Fosun Pharma

11.14.1 Fosun Pharma Company Detail

11.14.2 Fosun Pharma Business Overview

11.14.3 Fosun Pharma In-Vitro Cancer Diagnostics Introduction

11.14.4 Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)

11.14.5 Fosun Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

MDx Health Quest Diagnostics

R-Biopharm AG

Signature Diagnostics

Amoy Diagnostics Co.,Ltd.

DAAN Gene

Fosun Pharma

List of Tables

Table 1. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Instruments

Table 3. Key Players of Reagents and Kits

Table 4. Global In-Vitro Cancer Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global In-Vitro Cancer Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global In-Vitro Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global In-Vitro Cancer Diagnostics Market Share by Region (2019-2024)

Table 8. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global In-Vitro Cancer Diagnostics Market Share by Region (2025-2030)

Table 10. In-Vitro Cancer Diagnostics Market Trends

Table 11. In-Vitro Cancer Diagnostics Market Drivers

Table 12. In-Vitro Cancer Diagnostics Market Challenges

Table 13. In-Vitro Cancer Diagnostics Market Restraints

Table 14. Global In-Vitro Cancer Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global In-Vitro Cancer Diagnostics Market Share by Players (2019-2024)

Table 16. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Cancer Diagnostics as of 2023)

Table 17. Ranking of Global Top In-Vitro Cancer Diagnostics Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by In-Vitro Cancer Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players In-Vitro Cancer Diagnostics Product Solution and Service

Table 21. Date of Enter into In-Vitro Cancer Diagnostics Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global In-Vitro Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2019-2024)

Table 25. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2025-2030)

Table 27. Global In-Vitro Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2019-2024)

Table 29. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2025-2030)

Table 31. North America In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 46. MDx Health Quest Diagnostics Company Detail

Table 47. MDx Health Quest Diagnostics Business Overview

Table 48. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product

Table 49. MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 50. MDx Health Quest Diagnostics Recent Development

Table 51. R-Biopharm AG Company Detail

Table 52. R-Biopharm AG Business Overview

Table 53. R-Biopharm AG In-Vitro Cancer Diagnostics Product

Table 54. R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 55. R-Biopharm AG Recent Development

Table 56. Signature Diagnostics Company Detail

Table 57. Signature Diagnostics Business Overview

Table 58. Signature Diagnostics In-Vitro Cancer Diagnostics Product

Table 59. Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 60. Signature Diagnostics Recent Development

Table 61. Siemens Healthcare Company Detail

Table 62. Siemens Healthcare Business Overview

Table 63. Siemens Healthcare In-Vitro Cancer Diagnostics Product

Table 64. Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 65. Siemens Healthcare Recent Development

Table 66. Randox Laboratories Company Detail

Table 67. Randox Laboratories Business Overview

Table 68. Randox Laboratories In-Vitro Cancer Diagnostics Product

Table 69. Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 70. Randox Laboratories Recent Development

Table 71. Epigenomics AG Company Detail

Table 72. Epigenomics AG Business Overview

Table 73. Epigenomics AG In-Vitro Cancer Diagnostics Product

Table 74. Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 75. Epigenomics AG Recent Development

Table 76. Beckman Coulter Company Detail

Table 77. Beckman Coulter Business Overview

Table 78. Beckman Coulter In-Vitro Cancer Diagnostics Product

Table 79. Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 80. Beckman Coulter Recent Development

Table 81. Abbott Laboratories Company Detail

Table 82. Abbott Laboratories Business Overview

Table 83. Abbott Laboratories In-Vitro Cancer Diagnostics Product

Table 84. Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 85. Abbott Laboratories Recent Development

Table 86. Burning Rock Company Detail

Table 87. Burning Rock Business Overview

Table 88. Burning Rock In-Vitro Cancer Diagnostics Product

Table 89. Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 90. Burning Rock Recent Development

Table 91. Novogene Company Detail

Table 92. Novogene Business Overview

Table 93. Novogene In-Vitro Cancer Diagnostics Product

Table 94. Novogene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 95. Novogene Recent Development

Table 96. Geneseeq Company Detail

Table 97. Geneseeq Business Overview

Table 98. Geneseeq In-Vitro Cancer Diagnostics Product

Table 99. Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 100. Geneseeq Recent Development

Table 101. Amoy Diagnostics Co.,Ltd. Company Detail

Table 102. Amoy Diagnostics Co.,Ltd. Business Overview

Table 103. Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product

Table 104. Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 105. Amoy Diagnostics Co.,Ltd. Recent Development

Table 106. Daan Gene Company Detail

Table 107. Daan Gene Business Overview

Table 108. Daan Gene In-Vitro Cancer Diagnostics Product

Table 109. Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 110. Daan Gene Recent Development

Table 111. Fosun Pharma Company Detail

Table 112. Fosun Pharma Business Overview

Table 113. Fosun Pharma In-Vitro Cancer Diagnostics Product

Table 114. Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 115. Fosun Pharma Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Global In-Vitro Cancer Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global In-Vitro Cancer Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Instruments Features

Figure 4. Reagents and Kits Features

Figure 5. Global In-Vitro Cancer Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global In-Vitro Cancer Diagnostics Market Share by Application: 2023 VS 2030

Figure 7. Laboratories Case Studies

Figure 8. Hospitals Case Studies

Figure 9. Others Case Studies

Figure 10. In-Vitro Cancer Diagnostics Report Years Considered

Figure 11. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global In-Vitro Cancer Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global In-Vitro Cancer Diagnostics Market Share by Region: 2023 VS 2030

Figure 14. Global In-Vitro Cancer Diagnostics Market Share by Players in 2023

Figure 15. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Cancer Diagnostics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by In-Vitro Cancer Diagnostics Revenue in 2023

Figure 17. North America In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)

Figure 19. United States In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)

Figure 23. Germany In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Region (2019-2030)

Figure 31. China In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)

Figure 39. Mexico In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)

Figure 43. Turkey In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. MDx Health Quest Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 46. R-Biopharm AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 47. Signature Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 48. Siemens Healthcare Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 49. Randox Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 50. Epigenomics AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 51. Beckman Coulter Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 52. Abbott Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 53. Burning Rock Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 54. Novogene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 55. Geneseeq Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 56. Amoy Diagnostics Co.,Ltd. Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 57. Daan Gene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 58. Fosun Pharma Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions